Evaluation of clinical outcomes in patients with dry eye disease using lubricant eye drops containing polyethylene glycol or carboxymethylcellulose
Authors:
Open Access
- 1 December 2013
- journal article
- research article
- Published by Taylor & Francis in Clinical Ophthalmology
- Vol. 8, 157-164
Abstract
Background: The purpose of this study was to compare changes in corneal staining in patients with dry eye after 6 weeks of treatment with Systane® Gel Drops or Refresh Liquigel® lubricant eye drops. Methods: Patients aged ≥18 years with a sodium fluorescein corneal staining sum score of ≥3 in either eye and best-corrected visual acuity of 0.6 logarithm of the minimum angle of resolution or better in each eye who were using a lubricant eye gel or ointment for dry eye were included in this randomized, parallel-group, multicenter, double-blind trial. Patients were randomized to four times daily Systane® Gel Drops (polyethylene glycol 400 0.4% and propylene glycol 0.3%) or Refresh LiquiGel® Drops (carboxymethylcellulose sodium 1%) for 6 weeks. The primary efficacy outcome was mean change from baseline to week 6 in sodium fluorescein corneal staining. Supportive efficacy outcomes included conjunctival staining, tear film break-up time, Patient Global Assessment of Improvement, Impact of Dry Eye on Everyday Life (IDEEL) Treatment Satisfaction/Treatment Bother Questionnaire, Single Symptom Comfort Scale, and Ocular Symptoms Questionnaire. The safety analysis comprised recording of adverse events. Results: In total, 147 patients (Systane group, n=73; Refresh group, n=74; mean ± standard deviation age, 57±16 years) were enrolled and included in the safety and efficacy analyses. Corneal staining was significantly reduced from baseline to week 6 for Systane and Refresh (−3.4±2.5 and −2.5±2.6 units, respectively; Pt-test), with a significantly greater improvement with Systane versus Refresh (P=0.0294). Results for conjunctival staining, tear film break-up time, and patient-reported outcome questionnaires were not statistically different between groups. No safety issues were identified; adverse events were reported by 19% of patients with Systane and 30% of patients with Refresh eye drops. Conclusion: Systane Gel Drops were associated with significantly better corneal staining scores versus Refresh Liquigel eye drops in patients with dry eye. Supportive efficacy outcomes were not significantly different between groups. Both treatments were well tolerated.Keywords
This publication has 18 references indexed in Scilit:
- Clinical Utility of Objective Tests for Dry Eye DiseaseCornea, 2012
- Prospective, Randomized, Controlled Comparison of SYSTANE UD Eye Drops Versus VISINE INTENSIV 1% EDO Eye Drops for the Treatment of Moderate Dry EyeJournal of Ocular Pharmacology and Therapeutics, 2012
- Evaluation of Dry EyeSurvey of Ophthalmology, 2012
- Distribution of Aqueous-Deficient and Evaporative Dry Eye in a Clinic-Based Patient CohortCornea, 2012
- Report of the TFOS/ARVO Symposium on Global Treatments for Dry Eye Disease: An Unmet NeedThe Ocular Surface, 2012
- Comparison of the clinical effects of carbomer-based lipid-containing gel and hydroxypropyl-guar gel artificial tear formulations in patients with dry eye syndrome: A 4-week, prospective, open-label, randomized, parallel-group, noninferiority studyClinical Therapeutics, 2010
- The challenge of dry eye diagnosisClinical Ophthalmology, 2008
- Methodologies to Diagnose and Monitor Dry Eye Disease: Report of the Diagnostic Methodology Subcommittee of the International Dry Eye WorkShop (2007)The Ocular Surface, 2007
- Patient-Reported Symptoms in Dry Dye DiseaseThe Ocular Surface, 2006
- The Repeatability of Clinical Measurements of Dry EyeCornea, 2004